Meridian Bioscience

Meridian Bioscience is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Our products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections.
In addition, we develop and manufacture a variety of biological and non-biological materials used in proficiency testing programs.

Company Growth (employees)
Cincinnati, US
Size (employees)
650 (est)
Meridian Bioscience was founded in 1977 and is headquartered in Cincinnati, US

Meridian Bioscience Office Locations

Meridian Bioscience has an office in Cincinnati
Cincinnati, US (HQ)
3471 River Hills Dr

Meridian Bioscience Financials and Metrics

Meridian Bioscience Financials

Meridian Bioscience's revenue was reported to be $196.1 m in FY, 2016

Revenue (Q3, 2017)

50.1 m

Gross profit (Q3, 2017)

31.2 m

Gross profit margin (Q3, 2017), %


Net income (Q3, 2017)

240 k

EBIT (Q3, 2017)

4.3 m

Market capitalization (13-Nov-2017)

621.9 m

Cash (30-Jun-2017)

55.3 m


622.4 m
Meridian Bioscience's current market capitalization is $621.9 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


188.7 m188.8 m194.8 m196.1 m

Revenue growth, %


Cost of goods sold

67.6 m71.6 m72.9 m68.3 m

Gross profit

121 m117.2 m121.9 m127.8 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


44.8 m50.1 m47.2 m48 m51.5 m48.2 m47.2 m51.3 m50.7 m46.8 m54.1 m50.1 m

Cost of goods sold

16.8 m18.5 m18 m18.8 m19 m17.9 m15.6 m17.7 m17.8 m17.4 m20.6 m18.9 m

Gross profit

28 m31.6 m29.2 m29.2 m32.5 m30.3 m31.6 m33.6 m32.9 m29.5 m33.5 m31.2 m

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


44.3 m43 m50 m47.2 m


34.8 m35.5 m35.8 m45.1 m

Current Assets

114.1 m112.7 m122.9 m126.8 m


23.1 m23.2 m22.3 m62 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


43.7 m38.2 m39.3 m49.5 m42.7 m46 m53.4 m48.9 m45.8 m49.3 m54.7 m55.3 m


37.7 m38.1 m37.6 m34.4 m33 m33.6 m38.8 m41.9 m43.4 m44.7 m42.4 m40.9 m

Current Assets

111.2 m114 m113.5 m114.7 m116.5 m118 m123.2 m128.2 m126.9 m126 m128.8 m129.2 m


23.4 m23.5 m23.8 m22.6 m22.1 m22.8 m22.1 m64.5 m63.7 m60.7 m60.8 m54.6 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

38 m34.7 m35.5 m32.2 m

Cash From Operating Activities

44.4 m38.3 m42.8 m37.2 m

Purchases of PP&E

(3.2 m)(5.3 m)(4.6 m)(4 m)

Cash From Investing Activities

(3.3 m)(7 m)(3.6 m)(66.7 m)
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

7.4 m10.3 m8.8 m7.9 m10.1 m27.1 m8.9 m18 m26.7 m6.3 m15.6 m15.8 m


33.6 m38.8 m41.9 m43.4 m44.7 m42.4 m

Accounts Payable

5.5 m7.2 m7.9 m7.4 m7.5 m6.4 m

Dividends Paid

(25 m)(8.4 m)(16.8 m)(25.2 m)(8.4 m)(13.7 m)(19 m)
USDY, 2017


144.6 x


77.1 k

Financial Leverage

1.5 x
Show all financial metrics

Meridian Bioscience Market Value History

Meridian Bioscience's Web-traffic and Trends

Meridian Bioscience Online and Social Media Presence

Meridian Bioscience Company Life and Culture

You may also be interested in